ARWR Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 5.00%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $6,865,286.56

Arrowhead Pharmaceuticals Insider Trading History Chart

Arrowhead Pharmaceuticals Share Price & Price History

^$36.27

▲ +0.15 (0.42%)

As of 06/7/2023 02:52 PM ET

Days: 30 | 90 | 365

Disturbing Truth About Biden's New Program To Seize Your Cash

From Investor Place Media | Ad

A former bank regulator is blowing the whistle on Biden's frightening plan to take over your money. Discover the immediate steps you need to take now.

Get The Rest Of The Details Here

Arrowhead Pharmaceuticals Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
5/5/2023	Douglas B Given	Director	Sell	6,500	$40.90	$265,850.00	117,635
5/3/2023	Christopher Richard Anzalone	CEO	Sell	54,928	$39.14	$2,149,881.92	3,761,338
3/3/2023	Adeoye Y. Olukotun	Director	Sell	11,350	$32.65	$370,577.50	7,867
2/27/2023	Douglas B Given	Director	Sell	875	$32.62	$28,542.50	13,000
1/9/2023	William D. Waddill	Director	Sell	3,200	$30.00	$96,000.00	28,950
1/5/2023	James C Hamilton	Insider	Sell	13,803	$37.40	$516,232.20	191,484
1/5/2023	Patrick C. O'Brien	COO	Sell	15,000	$37.39	$560,850.00	413,375
1/3/2023	James C Hamilton	Insider	Sell	10,338	$38.38	$396,772.44	145,287
1/3/2023	Patrick C. O'Brien	COO	Sell	17,500	$38.33	$670,775.00	363,375
12/29/2022	Kenneth Allen Myszkowski	CFO	Sell	30,625	$40.00	$1,225,000.00	336,704
11/21/2022	Javier San Martin	Insider	Sell	19,500	$29.99	$584,805.00	91,500
2/11/2022	Christopher Richard Anzalone	CEO	Sell	146,388	$51.91	$7,599,001.08
1/5/2022	Kenneth Allen Myszkowski	CFO	Sell	40,000	$61.70	$2,468,000.00
1/5/2022	Patrick C. O'Brien	General Counsel	Sell	32,500	$61.72	$2,005,900.00
1/4/2022	James C Hamilton	SVP	Sell	19,375	$65.49	$1,268,868.75
1/3/2022	William D. Waddill	Director	Sell	4,500	$64.72	$291,240.00
12/28/2021	Douglas B Given	Director	Buy	655	$66.37	$43,472.35
12/15/2021	Christopher Richard Anzalone	CEO	Sell	60,000	$67.56	$4,053,600.00
11/19/2021	Javier San Martin	Insider	Sell	19,500	$69.31	$1,351,545.00
10/22/2021	Christopher Richard Anzalone	CEO	Sell	50,000	$65.63	$3,281,500.00
10/20/2021	Christopher Richard Anzalone	CEO	Sell	15,000	$66.23	$993,450.00
9/13/2021	Adeoye Y. Olukotun	Director	Sell	5,000	$63.76	$318,800.00
6/24/2021	Marianne De Backer	Director	Sell	5,000	$89.85	$449,250.00
6/22/2021	Douglass B. Given	Director	Sell	4,500	$89.21	$401,445.00
6/22/2021	James Hassard	Insider	Sell	3,625	$89.22	$323,422.50
2/8/2021	Patrick C. O'Brien	General Counsel	Sell	90,000	$88.46	$7,961,400.00	383,375
1/15/2021	Douglass B. Given	Director	Sell	3,000	$83.28	$249,840.00
1/14/2021	James C Hamilton	SVP	Sell	10,000	$81.29	$812,900.00	130,064
1/12/2021	Kenneth Allen Myszkowski	CFO	Sell	13,038	$81.02	$1,056,338.76	445,446
1/7/2021	James Hassard	Insider	Sell	15,625	$75.00	$1,171,875.00	109,375
1/6/2021	Kenneth Allen Myszkowski	CFO	Sell	30,625	$72.44	$2,218,475.00	486,568
1/6/2021	Patrick C. O'Brien	General Counsel	Sell	25,000	$72.41	$1,810,250.00	317,233
1/5/2021	James C Hamilton	SVP	Sell	19,375	$72.53	$1,405,268.75	171,200
1/4/2021	Douglas B Given	Director	Sell	4,000	$76.08	$304,320.00
12/17/2020	Douglass B. Given	Director	Sell	9,575	$79.32	$759,489.00
12/10/2020	William D. Waddill	Director	Sell	3,000	$71.26	$213,780.00	26,800
12/9/2020	Christopher Richard Anzalone	CEO	Sell	38,676	$69.06	$2,670,964.56	2,521,561
11/19/2020	Javier San Martin	Insider	Sell	19,500	$69.39	$1,353,105.00	130,500
10/23/2020	Christopher Richard Anzalone	CEO	Sell	100,000	$58.21	$5,821,000.00
10/20/2020	Kenneth Allen Myszkowski	CFO	Sell	29,166	$54.04	$1,576,130.64	456,834
10/9/2020	Mauro Ferrari	Director	Sell	10,000	$48.00	$480,000.00	30,971
8/13/2020	Christopher Richard Anzalone	CEO	Sell	50,000	$41.35	$2,067,500.00	2,655,237
6/25/2020	Christopher Richard Anzalone	CEO	Sell	100,000	$38.81	$3,881,000.00	2,605,260
6/15/2020	Marianne De Backer	Director	Buy	500	$31.33	$15,665.00	13,000
3/16/2020	Marianne De Backer	Director	Buy	500	$23.94	$11,970.00	13,000
3/11/2020	Marianne De Backer	Director	Buy	500	$28.60	$14,300.00	13,000
2/27/2020	Marianne De Backer	Director	Buy	500	$35.07	$17,535.00	13,000
1/13/2020	Marianne De Backer	Director	Buy	500	$54.95	$27,475.00	13,000

Passive Income Powerhouse Unveiled: The Ultimate Play!

From The Oxford Club | Ad

The #1 income play for 2023 is NOT a stock, bond or private company... Rather, it's a little-known alternative investment that could hand you big monthly income from oil and gas.

Find Out What It Is Right Here.

>>>

SEC Filings (Institutional Ownership Changes) for Arrowhead Pharmaceuticals (NASDAQ:ARWR)

65.46% of Arrowhead Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Arrowhead Pharmaceuticals Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
6/5/2023	EP Wealth Advisors LLC	8,500	$0.22M	0.0%	N/A	0.008%
5/26/2023	ProShare Advisors LLC	26,068	$0.66M	0.0%	-13.5%	0.024%
5/23/2023	Capital Impact Advisors LLC	15,418	$0.39M	0.5%	-42.6%	0.014%
5/22/2023	Putnam Investments LLC	50,409	$1.28M	0.0%	-4.0%	0.047%
5/22/2023	Ameriprise Financial Inc.	466,278	$11.84M	0.0%	-7.8%	0.436%
5/18/2023	JPMorgan Chase & Co.	2,909,965	$73.91M	0.0%	+3.2%	2.722%
5/18/2023	New York State Common Retirement Fund	53,200	$1.35M	0.0%	-84.9%	0.050%
5/17/2023	Thrivent Financial for Lutherans	28,584	$0.73M	0.0%	+1.4%	0.027%
5/16/2023	Hudson Bay Capital Management LP	147,500	$3.75M	0.0%	N/A	0.138%
5/16/2023	Cim Investment Management Inc.	8,648	$0.22M	0.1%	+57.4%	0.008%
5/16/2023	Silvercrest Asset Management Group LLC	85,507	$2.17M	0.0%	N/A	0.080%
5/16/2023	State Street Corp	5,902,768	$149.93M	0.0%	-1.1%	5.522%
5/16/2023	Squarepoint Ops LLC	192,686	$4.89M	0.0%	+3,003.3%	0.180%
5/16/2023	First Trust Advisors LP	65,607	$1.67M	0.0%	+431.7%	0.061%
5/16/2023	Geode Capital Management LLC	2,078,527	$52.80M	0.0%	+5.3%	1.944%
5/16/2023	Balyasny Asset Management L.P.	275,788	$7.01M	0.0%	+5,026.2%	0.258%
5/15/2023	WCM Investment Management LLC	141,409	$3.59M	0.0%	-3.9%	0.132%
5/15/2023	Nomura Holdings Inc.	761,147	$19.33M	0.1%	+17.2%	0.712%
5/15/2023	Pensionmark Financial Group LLC	20,061	$0.51M	0.1%	-2.7%	0.019%
5/15/2023	Bayesian Capital Management LP	32,682	$0.83M	0.1%	N/A	0.031%
5/15/2023	Commodore Capital LP	575,000	$14.61M	2.2%	+24.4%	0.538%
5/15/2023	Delphia USA Inc.	9,923	$0.25M	0.3%	+37.5%	0.009%
5/15/2023	Corton Capital Inc.	12,244	$0.31M	0.2%	+55.9%	0.011%
5/15/2023	Two Sigma Advisers LP	32,000	$0.81M	0.0%	N/A	0.030%
5/15/2023	Two Sigma Investments LP	90,300	$2.29M	0.0%	+547.5%	0.084%
5/15/2023	Deutsche Bank AG	244,441	$6.21M	0.0%	+7.8%	0.229%
5/15/2023	Ensign Peak Advisors Inc	50,990	$1.30M	0.0%	-71.4%	0.048%
5/15/2023	Price T Rowe Associates Inc. MD	52,020	$1.32M	0.0%	+2.5%	0.049%
5/15/2023	Seven Eight Capital LP	40,176	$1.02M	0.2%	N/A	0.038%
5/12/2023	Renaissance Technologies LLC	292,800	$7.44M	0.0%	-40.7%	0.274%
5/12/2023	State of Tennessee Treasury Department	56,323	$1.43M	0.0%	-6.1%	0.053%
5/12/2023	Candriam S.C.A.	288,054	$6.73M	0.0%	-19.6%	0.269%
5/12/2023	Great West Life Assurance Co. Can	83,421	$2.12M	0.0%	+17.3%	0.078%
5/12/2023	BlackRock Inc.	12,710,801	$322.85M	0.0%	0.0%	11.890%
5/12/2023	BNP Paribas Arbitrage SNC	156,880	$3.99M	0.0%	+59.0%	0.147%
5/12/2023	Bank of America Corp DE	475,767	$12.08M	0.0%	-28.6%	0.445%
5/12/2023	O Shaughnessy Asset Management LLC	10,014	$0.25M	0.0%	-14.2%	0.009%
5/12/2023	HRT Financial LP	15,846	$0.40M	0.0%	N/A	0.015%
5/12/2023	UBS Group AG	299,342	$7.60M	0.0%	-2.7%	0.280%
5/12/2023	NewEdge Advisors LLC	1,443	$37K	0.0%	-43.3%	0.001%
5/12/2023	Blair William & Co. IL	14,490	$0.37M	0.0%	-3.8%	0.014%
5/12/2023	Atlantic Private Wealth LLC	3,000	$76K	0.1%	-60.5%	0.003%
5/12/2023	Wellington Management Group LLP	29,297	$0.74M	0.0%	-31.5%	0.027%
5/12/2023	Panagora Asset Management Inc.	250,581	$6.37M	0.0%	+1.9%	0.234%
5/12/2023	ProShare Advisors LLC	26,068	$0.66M	0.0%	-13.5%	0.024%
5/12/2023	Charles Schwab Investment Management Inc.	1,157,575	$29.40M	0.0%	+1.7%	1.083%
5/12/2023	Profund Advisors LLC	52,802	$1.34M	0.1%	+193.4%	0.049%
5/12/2023	Platinum Investment Management Ltd.	76,208	$1.94M	0.1%	N/A	0.071%
5/12/2023	HighTower Advisors LLC	33,552	$0.87M	0.0%	+6.4%	0.031%
5/11/2023	FMR LLC	1,373,247	$34.88M	0.0%	-31.0%	1.285%
5/11/2023	ExodusPoint Capital Management LP	13,860	$0.35M	0.0%	-58.5%	0.013%
5/11/2023	Rhumbline Advisers	345,485	$8.78M	0.0%	-0.2%	0.323%
5/11/2023	Commonwealth Equity Services LLC	34,172	$0.87M	0.0%	+444.9%	0.032%
5/11/2023	E Fund Management Co. Ltd.	14,679	$0.37M	0.0%	+5.0%	0.014%
5/10/2023	Private Advisor Group LLC	11,795	$0.30M	0.0%	N/A	0.011%
5/10/2023	Credit Suisse AG	1,387,086	$35.23M	0.0%	+3.6%	1.298%
5/10/2023	Pictet Asset Management SA	12,327	$0.31M	0.0%	+6.8%	0.012%
5/10/2023	Swiss National Bank	217,300	$5.52M	0.0%	-10.5%	0.203%
5/9/2023	Principal Financial Group Inc.	444,017	$11.28M	0.0%	+2.6%	0.415%
5/9/2023	Kornitzer Capital Management Inc. KS	126,510	$3.21M	0.1%	+28.0%	0.118%
5/9/2023	Tower Research Capital LLC TRC	6,506	$0.17M	0.0%	+33.6%	0.006%
5/9/2023	Evolutionary Tree Capital Management LLC	51,878	$1.32M	1.8%	-43.7%	0.049%
5/9/2023	Commonwealth of Pennsylvania Public School Empls Retrmt SYS	48,783	$1.24M	0.0%	+2.4%	0.046%
5/9/2023	Bank of New York Mellon Corp	1,039,993	$26.42M	0.0%	-2.5%	0.973%
5/9/2023	California State Teachers Retirement System	126,766	$3.22M	0.0%	-1.5%	0.119%
5/9/2023	US Bancorp DE	42,743	$1.09M	0.0%	+138.0%	0.040%
5/9/2023	Russell Investments Group Ltd.	227,898	$5.79M	0.0%	-8.3%	0.213%
5/8/2023	Eagle Asset Management Inc.	416,005	$10.57M	0.1%	-8.6%	0.389%
5/8/2023	Federated Hermes Inc.	9,541	$0.24M	0.0%	-18.2%	0.009%
5/8/2023	Zurcher Kantonalbank Zurich Cantonalbank	17,739	$0.45M	0.0%	+19.9%	0.017%
5/5/2023	Assetmark Inc.	56,549	$1.44M	0.0%	-32.7%	0.053%
5/4/2023	Oregon Public Employees Retirement Fund	31,608	$0.80M	0.0%	+1.4%	0.029%
5/4/2023	Barclays PLC	315,982	$8.03M	0.0%	-6.8%	0.292%
5/4/2023	Mirae Asset Global Investments Co. Ltd.	330,658	$8.40M	0.0%	+4.3%	0.305%
5/4/2023	Wealth Effects LLC	156,810	$3.98M	2.0%	+0.8%	0.145%
5/4/2023	Mutual of America Capital Management LLC	136,677	$3.47M	0.0%	-1.5%	0.126%
5/4/2023	Los Angeles Capital Management LLC	8,510	$0.22M	0.0%	-34.6%	0.008%
5/3/2023	Jump Financial LLC	22,946	$0.58M	0.0%	N/A	0.021%
5/3/2023	TCI Wealth Advisors Inc.	2,127	$54K	0.0%	+25.6%	0.002%
5/3/2023	Privium Fund Management B.V.	259,036	$6.58M	2.2%	+17.2%	0.239%
5/3/2023	New Mexico Educational Retirement Board	19,200	$0.49M	0.0%	+15.7%	0.018%
5/2/2023	Yousif Capital Management LLC	55,612	$1.41M	0.0%	+2.1%	0.051%
5/2/2023	Pacer Advisors Inc.	8,520	$0.22M	0.0%	-58.0%	0.008%
5/2/2023	Victory Capital Management Inc.	49,815	$1.27M	0.0%	-18.1%	0.046%
5/2/2023	Nisa Investment Advisors LLC	2,005	$51K	0.0%	-73.8%	0.002%
5/2/2023	Amalgamated Bank	71,700	$1.82M	0.0%	-3.6%	0.066%
5/1/2023	Texas Permanent School Fund Corp	97,133	$2.47M	0.0%	+36.5%	0.090%
5/1/2023	Retirement Systems of Alabama	334,720	$8.50M	0.0%	+0.6%	0.309%
5/1/2023	Banque Pictet & Cie SA	169,954	$4.32M	0.0%	-11.8%	0.157%
5/1/2023	CWM LLC	86,397	$2.19M	0.0%	-4.5%	0.080%
4/28/2023	Dupont Capital Management Corp	2,206	$56K	0.0%	-16.0%	0.002%
4/28/2023	SG Americas Securities LLC	8,048	$0.20M	0.0%	-67.4%	0.007%
4/28/2023	State of Michigan Retirement System	27,370	$0.70M	0.0%	+1.5%	0.025%
4/28/2023	China Universal Asset Management Co. Ltd.	1,467	$37K	0.0%	+36.2%	0.001%
4/27/2023	Stratos Wealth Partners LTD.	9,440	$0.24M	0.0%	+13.6%	0.009%
4/27/2023	Arizona State Retirement System	29,179	$0.74M	0.0%	+2.8%	0.027%
4/27/2023	Strs Ohio	26,200	$0.67M	0.0%	-23.2%	0.024%
4/26/2023	State of New Jersey Common Pension Fund D	70,670	$1.80M	0.0%	-10.8%	0.065%
4/26/2023	Harbor Capital Advisors Inc.	15,662	$0.40M	0.1%	-8.5%	0.014%
4/26/2023	Fiera Capital Corp	59,028	$1.50M	0.0%	-94.6%	0.054%

Data available starting January 2016

Arrowhead Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development of medicines that treat intractable diseases by silencing the genes that cause them. The firms preclinical stage drug candidates include ARO-ANG3, ARO-AAT, ARO-APOC3, ARO-HIF2, ARO-HSD, ARO-Lung2, ARO-COV, and ARO-ENaC. The company was founded by R. Bruce Stewart in 1989 and is headquartered in Pasadena, CA.

Today's Range

Now: $36.27

$35.38

$36.75

50 Day Range

MA: $33.31

$24.43

$41.38

52 Week Range

Now: $36.27

$23.09

$48.48

Volume

249,004 shs

Average Volume

1,080,973 shs

Market Capitalization

$3.88 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.99

Who are the company insiders with the largest holdings of Arrowhead Pharmaceuticals?: Arrowhead Pharmaceuticals' top insider shareholders include:
Christopher Richard Anzalone (CEO)
Patrick O'brien (COO)
Kenneth Allen Myszkowski (CFO)
James C Hamilton (Insider)
Douglas B Given (Director)
Martin Javier San (Insider)
William D Waddill (Director)
Adeoye Y Olukotun (Director)
Backer Marianne De (Director)
Douglas B Given (Director)
James C Hamilton (SVP)
James Hassard (Insider)
Patrick O'brien (General Counsel)
Learn More about top insider investors at Arrowhead Pharmaceuticals.
Who are the major institutional investors of Arrowhead Pharmaceuticals?: Arrowhead Pharmaceuticals' top institutional shareholders include:
BlackRock Inc. — 11.89%
State Street Corp — 5.52%
JPMorgan Chase & Co. — 2.72%
Geode Capital Management LLC — 1.94%
Credit Suisse AG — 1.30%
FMR LLC — 1.28%
Learn More about top institutional investors of Arrowhead Pharmaceuticals stock.
Which institutional investors are selling Arrowhead Pharmaceuticals stock?: During the last quarter, ARWR stock was sold by these institutional investors:
Fiera Capital Corp
FMR LLC
New York State Common Retirement Fund
Renaissance Technologies LLC
Bank of America Corp DE
Ensign Peak Advisors Inc
Candriam S.C.A.
State Street Corp
In the last year, company insiders that have sold Arrowhead Pharmaceuticals company stock include:
Christopher Richard Anzalone (CEO)
Patrick O'brien (COO)
Kenneth Allen Myszkowski (CFO)
James C Hamilton (Insider)
Douglas B Given (Director)
Martin Javier San (Insider)
William D Waddill (Director)
Adeoye Y Olukotun (Director)
Learn More investors selling Arrowhead Pharmaceuticals stock.
Which institutional investors are buying Arrowhead Pharmaceuticals stock?: Within the last quarter, ARWR stock was acquired by institutional investors including:
Assenagon Asset Management S.A.
Balyasny Asset Management L.P.
Squarepoint Ops LLC
Hudson Bay Capital Management LP
Commodore Capital LP
Nomura Holdings Inc.
Geode Capital Management LLC
JPMorgan Chase & Co.